Current News

WALBROOK PR Welcomes Belluscura To AIM

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it has acted as Financial PR & Investor Relations advisor for the AIM IPO of Belluscura plc (AIM: “BELL”), a leading medical device developer focused on lightweight and portable oxygen enrichment technology. The team at Walbrook will now manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

28 May 2021  •  Read more

Walbrook PR Appointed By Nuformix plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to Nuformix plc (LSE:NFX), a pharmaceutical development company and drug repurposing specialist. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 May 2021  •  Read more

WALBROOK PR Appointed By Hargreaves Services plc

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as PR & IR advisor to Hargreaves Services plc (“Hargreaves”), a diversified group delivering services to the industrial and property sectors. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 April 2021  •  Read more

Walbrook PR Appointed by Induction Healthcare Group plc

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as PR & IR advisor to Induction Healthcare Group plc (“Induction”), a leading healthcare technology company that helps to digitally transform hospitals. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

05 March 2021  •  Read more

Walbrook PR Appointed By Reneuron Group Plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 March 2021  •  Read more

Walbrook PR Appointed By NetScientific plc

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as PR & IR advisor to NetScientific plc (“NetScientific”), the international investment and commercial advisory group for the life sciences and sustainability technology sectors. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 January 2021  •  Read more

Walbrook PR Appointed By Tissue Regenix Group plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Tissue Regenix Group plc, the regenerative medical devices company. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 January 2021  •  Read more

Walbrook PR AIM IPO - Intuitive Investments Group plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that it has acted as Financial PR & Investor Relations advisor to the recent AIM IPO of Intuitive Investments Group plc, the closed-end investment company focused on the life sciences sector. The team at Walbrook will now manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

14 December 2020  •  Read more

Walbrook PR appointed by Open Orphan plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM and Euronext listed Open Orphan plc, a rapidly growing specialist pharmaceutical services CRO which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 December 2020  •  Read more

Walbrook PR AIM IPO Autumn Brace Sourcebio International Plc & Verici Dx Plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that is has acted as Financial PR & Investor Relations advisor to two recent AIM IPOs: SourceBio International plc, a leading international provider of integrated state-of-the-art laboratory services and products, and Verici Dx plc, a developer of advanced clinical diagnostics for organ transplant. The team at Walbrook will now manage ongoing communications with the financial media, research analysts and non-institutional investors, including new and existing private investors for both companies.

19 November 2020  •  Read more

Walbrook PR appointed by Feedback PLC

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as PR & IR advisor to Feedback plc (“Feedback”), the specialist medical imaging technology company.

27 October 2020  •  Read more

Paul McManus, MD of Walbrook PR, writes for the Yorkshire Post

Long live the new-look AGM

06 October 2020  •  Read more

Paul McManus, MD of Walbrook PR, writes for the Yorkshire Post

Going online in lockdown has levelled the playing field for investors

02 October 2020  •  Read more

Walbrook PR appointed by Van Elle Holdings PLC

Walbrook PR Limited, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Van Elle Holdings plc (Van Elle), the UK-based provider of first-class ground engineering services and the largest contractor in their industry since 2018. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

14 September 2020  •  Read more

Walbrook PR appointed by Truspine Technologies plc for AQSE listing

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that it has acted as Financial PR & Investor Relations advisor to Truspine Technologies plc during their recent listing on the Aquis Stock Exchange (AQSE). Truspine Technologies plc is a medical device company focused on the USD$10.2 billion per annum spinal (vertebral) stabilisation market. Truspine raised gross proceeds of £1.4 million and was valued at £31.6 million on Admission to AQSE.

20 August 2020  •  Read more

Walbrook PR supports trio of stock exchange admissions

Walbrook PR Limited, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that it has supported the admissions of three companies to the UK’s public stock markets since the turn of the year.

20 May 2020  •  Read more

Paul McManus, MD of Walbrook PR, writes for the Yorkshire Post

AIM's companies show "Dunkirk Spirit" to battle pandemic

14 May 2020  •  Read more

Walbrook PR appointed by IXICO plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed IXICO plc

01 May 2020  •  Read more

Paul McManus, MD of Walbrook PR, writes for the Yorkshire Post

AIM's spirits are being revived

06 February 2020  •  Read more

Walbrook PR appointed by Concepta plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Concepta plc.

13 November 2019  •  Read more

Who We Work With

Polarean Imaging plc Genedrive plc Dillistone-Group-plc Westminster-Group-plc Tristel-plc Solid-State PCIPal_Logo_Main-CMYK OptiBiotix-logo GWM Filtronic EKF-Diagnostics-Holdings-plc Creo-Medical-logo OTAQ_Logo_Large Pennant-International-plc Van Elle plc Ilika-plc